Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trial
Michael Koren(Walter Reed Army Institute of Research), Kayvon Modjarrad(Pfizer (United States)), Rafael De La Barrera(Walter Reed Army Institute of Research), Jack Hutter, Sheila A. Peel(Henry M. Jackson Foundation), Mihret F. Amare(Henry M. Jackson Foundation), Nelson L. Michael(Walter Reed Army Institute of Research), Margaret C. Costanzo(Henry M. Jackson Foundation), Vincent Dussupt(Henry M. Jackson Foundation), Gregory D. Gromowski(Walter Reed Army Institute of Research), Tsedal Mebrahtu(Henry M. Jackson Foundation), Stephen J. Thomas(Global Viral), Shelly J. Krebs(Henry M. Jackson Foundation), Melinda Hamer, Trevor A. Crowell(Henry M. Jackson Foundation), Janice M. Darden(Henry M. Jackson Foundation), Kenneth H. Eckels(Walter Reed Army Institute of Research), Kristin T Mills(Walter Reed Army Institute of Research), Merlin L. Robb(University of Maryland, Baltimore), Richard G. Jarman(Walter Reed Army Institute of Research), Nathanial K. Copeland(Walter Reed Army Institute of Research), Erica L Sondergaard(Walter Reed Army Institute of Research), Paul B. Keiser(Walter Reed Army Institute of Research), Justin M Curley(Walter Reed Army Institute of Research), Anais Valencia-Ruiz(Henry M. Jackson Foundation), Christine Lee(Walter Reed Army Institute of Research), Gina Donofrio(Henry M. Jackson Foundation), Leyi Lin(Walter Reed Army Institute of Research), O.S. Adedeji(Emmes (United States))
Cited by 23
Related Papers
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys
|Nature|2012|466
A Recombinant Vesicular Stomatitis Virus Ebola Vaccine
|New England Journal of Medicine|2015|390